TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biomedica Norden AB
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 3,063 | 3,323 | 2,935 |
Financial expenses | 78 | 108 | 129 |
Earnings before taxes | -40 | -12 | -13 |
EBITDA | 372 | 459 | 483 |
Total assets | 1,841 | 2,375 | 2,610 |
Current assets | 535 | 597 | 427 |
Current liabilities | 505 | 942 | 1,227 |
Equity capital | 261 | 328 | 347 |
- share capital | 67 | 73 | 74 |
Employees (average) | 2 | 2 | 2 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 14.2% | 13.8% | 13.3% |
Turnover per employee | 1,532 | 1,662 | 1,468 |
Profit as a percentage of turnover | -1.3% | -0.4% | -0.4% |
Return on assets (ROA) | 2.1% | 4.0% | 4.4% |
Current ratio | 105.9% | 63.4% | 34.8% |
Return on equity (ROE) | -15.3% | -3.7% | -3.7% |
Change turnover | 9 | 444 | -54 |
Change turnover % | 0% | 15% | -2% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.